GBT - Global Blood Th Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 TVIX (0%) UGAZ (0%) VTVT (0%) TWTR (%) TPR (0%) SPY (0%) SMH (0%) ONCS (0%) OKTA (0%) NVDA (0%) NTRP (0%) LULU (0%) IWM (0%) ICLN (0%) HPQ (0%) GSKY (0%) GOGO (0%) FUNC (0%) FDX (0%) ESNT (0%) DVN (0%) DLR (0%) DIS (0%) AMD (0%)

GBT - Global Blood Therape...

$46.49 0[%]

15 mins delayed data

People also watch : OPHLY | ONCX | OMER

+Watchlist

3 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$46.49	Open
Volume		Market Cap	3.502B
Yield		Last Dividend

Day

52 Week

GBT Announces New Employment Inducement ...	10/07/19
SOUTH SAN FRANCISCO, Calif., Oct. 07, 2019 -- Global Blood Therapeutics, Inc., (GBT) (NASDAQ: GBT) today announced that on October 1, 2019, the compen...

GBT Announces Upcoming Presentations at ...	10/02/19
Global Blood Therapeutics, Inc. (GBT) (GBT) today announced that four abstracts related to its sickle cell disease (SCD) research have been accepted f...

GBT to Host Analyst & Investor Day on Oc...	10/01/19
SOUTH SAN FRANCISCO, Calif., Oct. 01, 2019 -- Global Blood Therapeutics, Inc., (GBT) (NASDAQ: GBT) today announced that it will host an Analyst & Inve...

ANALYST RATINGS

2 analyst ratings (Last 6 months)

50.00 %

Strong Buy + Buy

Price Target (PT)

Strong Buy rating	10/09/19
Wells Fargo maintains Outperform rating and raises Price Target from $96.00 to $104.00

Hold rating	05/29/19
and announces Price Target of $75.00

EARNINGS

Date	2019-08-07 (AMC)	Est. (EPS/Rev.)	($0.96)/ 0
Actual (EPS/Rev.)	$-1.01/	EPS (TTM)	0

TRADERS TRACKING $GBT

Service Name	Trader	% Success
Trading	Trading	99.00 %	Follow
Biotechnology	Robert Gadimian	26.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.

Total Revenue	$1.3B	Total Liabilities	$2.1B
Cost of Revenue	$2.5B	Total cash flow	$3.2
Total Assets	$29.98B

Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%
Vanguard	12.52% (+6.4%)	Bank of America	10.43%